Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mesoblast Limited (MESO)

  • Business News
  • Jan. 08, 2026, 22:57 UTC
  • 8
  • 1 comments

Ryoncil Sales for the Quarter Increase 60% to US$35.1M

Market reaction Comment Full text

CorMedix Inc. (CRMD)

  • Business News
  • Jan. 08, 2026, 22:22 UTC
  • 7
  • 1 comments

Notification from CorMedix Inc.

Market reaction Comment Full text

CONMED Corporation (CNMD)

  • Business News
  • Jan. 08, 2026, 21:55 UTC
  • 7
  • 1 comments

CONMED Corporation Announces Chief Financial Officer Transition

Market reaction Comment Full text

uniQure NV (QURE)

  • Business News
  • Jan. 08, 2026, 21:46 UTC
  • 8
  • 1 comments

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

Market reaction Comment Full text

Praxis Precisions Medicines Inc (PRAX)

  • Business News
  • Jan. 08, 2026, 21:45 UTC
  • 5
  • 1 comments

Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

Market reaction Comment Full text

Illumina Inc (ILMN)

  • Business News
  • Jan. 08, 2026, 21:31 UTC
  • 9
  • 1 comments

Illumina, Inc. - Illumina Appoints Dr. Eric Green as Chief Medical Officer

Market reaction Comment Full text

Quanterix Corp (QTRX)

  • Business News
  • Jan. 08, 2026, 21:30 UTC
  • 9
  • 1 comments

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Market reaction Comment Full text

Cellectis (CLLS)

  • Business News
  • Jan. 08, 2026, 21:30 UTC
  • 7
  • 1 comments

Cellectis Announces 2026 Strategy and Catalysts

Market reaction Comment Full text

PTC Therapeutics Inc (PTCT)

  • Business News
  • Jan. 08, 2026, 21:30 UTC
  • 8
  • 1 comments

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Emergent Biosolutions Inc. (EBS)

  • Business News
  • Jan. 08, 2026, 21:30 UTC
  • 7
  • 1 comments

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

Market reaction Comment Full text
  • Previous
  • 117
  • 118
  • 119
  • 120
  • 121
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin